PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$8.67
-0.27 (-3.02%)
Financial Highlights (FY 2026)
Revenue
2.10M
Net Income
27.93M
Gross Margin
-61.6%
Profit Margin
1,328.6%
Rev Growth
+81.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -61.6% -61.6% 44.0% 44.0%
Operating Margin 776.8% 699.1% 8.6% 7.3%
Profit Margin 1,328.6% 1,262.2% 6.6% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.10M 1.16M 6.38M 6.70M
Gross Profit -1,294,973 -713,051 2.81M 2.95M
Operating Income 16.33M 8.09M 548.6K 488.5K
Net Income 27.93M 13.84M 418.8K 465.2K
Gross Margin -61.6% -61.6% 44.0% 44.0%
Operating Margin 776.8% 699.1% 8.6% 7.3%
Profit Margin 1,328.6% 1,262.2% 6.6% 6.9%
Rev Growth +81.6% +81.6% +12.0% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.13M 1.84M
Total Equity 6.09M 6.42M
D/E Ratio 0.35 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 20.27M 10.61M 672.1K 715.5K
Free Cash Flow 349.1K 300.8K